title: Cardiovascular consequences of obesity: role of leptin.
abstract: 1. Several mechanisms have been implicated in the association between obesity and hypertension, including salt-sensitivity, insulin resistance and sympathetic activation. Obese animals and humans exhibit exaggerated blood pressure responses to increases in salt intake. 2. Although insulin resistance is common in obesity, it is clear that abnormal insulin action is not the sole or sufficient cause of hypertension in obesity. Obesity is associated with increased activity of the sympathetic nervous system. Sympathetic blockade has been reported to attenuate sodium retention and hypertension in experimental models of obesity. 3. The mediators responsible for salt sensitivity, insulin resistance and sympathetic activation in obesity remain unclear. 4. The novel protein hormone leptin is produced almost exclusively by adipose tissue and acts in the central nervous system through a specific receptor and multiple neuropeptide pathways to decrease appetite and increase energy expenditure. 5. Increasing evidence suggests that leptin may have wider actions influencing autonomic, cardiovascular, renal and endocrine function. We have shown that leptin increases sympathetic nerve activity to kidney, hindlimb and adrenal gland, in addition to brown adipose tissue. 6. Despite this sympathoexcitatory action, acute systemic administration of leptin does not acutely increase arterial pressure or heart rate in anaesthetized animals. This may reflect opposing antihypertensive actions of leptin. For example, leptin increases renal sodium and water excretion, apparently through a direct tubular action. In addition, leptin increases systemic insulin sensitivity, even in the absence of weight loss. 7. In conclusion, leptin may act as a mediator linking body adiposity with changes in insulin action, sympathetic neural outflow and renal sodium excretion. Alterations in leptin generation or action may, in part, underlie the sympathetic, endocrine and renal consequences of obesity.
authors.affiliation: Department of Internal Medicine, University of Iowa College of Medicine and Veterans Affairs Medical Center, Iowa City 52242, USA. william-g-haynes@uiowa.edu
authors.forename: W G
authors.initials: WG
authors.lastname: Haynes
authors.forename: D A
authors.initials: DA
authors.lastname: Morgan
authors.forename: S A
authors.initials: SA
authors.lastname: Walsh
authors.forename: W I
authors.initials: WI
authors.lastname: Sivitz
authors.forename: A L
authors.initials: AL
authors.lastname: Mark
mesh_terms: D000818:Animals; D002319:Cardiovascular System / Q000503:physiopathology*; D006801:Humans; D020738:Leptin; D009765:Obesity / Q000503:physiopathology*; D011506:Proteins / Q000502:physiology*
chemical_list: D020738:Leptin; D011506:Proteins